[1] 甲真菌病指南专家工作组. 中国甲真菌病诊疗指南(2021年版)[J]. 中国真菌学杂志,2022,17(1):1-7. [2] SONG G, ZHANG M J, LIU W D, et al. Epidemiology of onychomycosis in Chinese mainland:a 30-year retrospective study[J]. Mycopathologia, 2022,187(4):323-331. [3] BODMAN M A, KRISHNAMURTHY K. Onychomycosis. StatPearls Publishing,2022.https://www.ncbi.nlm.nih.gov/books/NBK441853/. [4] LIPNER S R, SCHER R K. Onychomycosis:Clinical overview and diagnosis[J]. J Am Acad Dermatol, 2019, 80(4):835-851. [5] GUPTA A K, STEC N, SUMMERBELL R C, et al. Onychomycosis:a review[J]. J Eur Acad Dermatol Venereol, 2020, 34(9):1972-1990. [6] STEWART C R, ALGU L, KAMRAN R, et al. Effect of onychomycosis and treatment on patient-reported quality-of-life outcomes:a systematic review[J]. J Am Acad Dermatol, 2021, 85(5):1227-1239. [7] FALOTICO J M, LIPNER S R. Updated perspectives on the diagnosis and management of onychomycosis[J]. Clin Cosmet Investig Dermatol, 2022, 15:1933-1957.DOI:10.2147/CCID.S362635. [8] GUPTA A K, VENKATARAMAN M, RENAUD H J, et al. A paradigm shift in the treatment and management of onychomycosis[J]. Skin Appendage Disord, 2021, 7(5):351-358. [9] 王冲,李明,王秀丽,等. 美浮特皮肤抗菌液治疗足癣多中心临床研究[J]. 中国真菌学杂志,2013,8(4):220-227. [10] JEFFCOATE W J, MUSGROVE A J, LINCOLN N B. Using image J to document healing in ulcers of the foot in diabetes[J]. Int Wound J, 2017, 14(6):1137-1139. [11] 潘炜华. 2015年版中国甲真菌病诊疗指南解读[J].世界临床药物,2016,37(2):73-76. [12] VLAHOVIC T C, GUPTA A K. Efinaconazole topical solution (10%) for the treatment of onychomycosis in adult and pediatric patients[J]. Expert Rev Anti Infect Ther, 2022, 20(1):3-15. [13] FOLEY K, GUPTA A K, VERSTEEG S, et al. Topical and device-based treatments for fungal infections of the toenails[J]. Cochrane Database Syst Rev, 2020, 1(1):CD012093. [14] GUPTA A K, VENKATARAMAN M, TALUKDER M. Onychomycosis in older adults:prevalence, diagnosis, and management[J]. Drugs Aging, 2022, 39(3):191-198. [15] SALAKSHNA N, BUNYARATAVE S, MATTHAPAN L, et al. A cohort study of risk factors, clinical presentations, and outcomes for dermatophyte, nondermatophyte, and mixed toenail infections[J]. J Am Acad Dermatol, 2018, 79(6):1145-1146. [16] 朱红梅,温海,许景峰,等. 美浮特皮肤抗菌液治疗部队足癣患者的疗效研究[J]. 中国真菌学杂志,2015,10(3):158-162. [17] 史冬梅,顾克斌,沈永年,等. 美浮特皮肤抗菌液对致足癣真菌抗真菌后效应的体外研究[J]. 中国真菌学杂志,2014,9(2):88-92. [18] 钟瑜,林少婷,覃芳敏,等. 苯扎氯铵消毒剂的抗菌性能研究[J]. 广东化工,2019,46(15):36-38. [19] CHOI H, KIM K J, LEE D G. Antifungal activity of the cationic antimicrobial polymer-polyhexamethylene guanidine hydrochloride and its mode of action[J]. Fungal Biol, 2017, 121(1):53-60. [20] GUPTA A K, WANG T, COOPER E A. Dermatophytomas:clinical overview and treatment[J]. J Fungi (Basel), 2022, 8(7):742. [21] CHETANA K, MENON R, DAVID B G. Onychoscopic evaluation of onychomycosis in a tertiary care teaching hospital:a cross-sectional study from South India[J]. Int J Dermatol, 2018, 57(7):837-842. [22] GUPTA A K, VERSTEEG S G, SHEAR N H, et al. A practical guide to curing onychomycosis:how to maximize cure at the patient, organism, treatment, and environmental level[J]. Am J Clin Dermatol, 2019, 20(1):123-133. [23] 中国中西医结合学会皮肤性病专业委员会真菌学组,中国医师协会皮肤科医师分会真菌亚专业委员会,中华医学会皮肤病学分会真菌学组. 手癣和足癣诊疗指南(2017修订版)[J]. 中国真菌学杂志,2017,12(6):321-324. |